The global small animal imaging market is estimated to grow from $XX million in 2018 to $XX million by 2027, at a CAGR of 8.94% between 2019 and 2027. The major drivers for the market are growing research and development funding by pharmaceutical and biotechnology companies for drug development.
The growth of small animal imaging market in Europe is primarily attributed to the increasing number of pre-clinical drug trials. In established European countries, the growth of the market is expected to remain stable, whereas, faster growth is expected in new European Union member states owing to considerable funding and modernization of healthcare facilities.
Small animal imaging market of Europe is mainly driven by increasing investment in clinical research, high adoption of imaging techniques during the drug development and discovery process, government support for drug discovery and development, and innovation in small animal imaging. The major countries considered for this market analysis are the United Kingdom, Spain, Italy, France, Germany and the Rest of Europe.
MILabs B.V., Miltenyi Biotec, ESaote S.P.A, GE Healthcare, Fujifilm Holdings Corporation, Perkinelmer, Inc., MR Solutions Ltd., Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Aspect Imaging, Hitachi Medical Corporation, Olympus Corporation, Siemens Healthcare GmbH, and MindRay are the major companies operating in the market.